南韩批准的三星星银河监视仪(Galaxy Watch AI)功能,未确定发射日期,通过ECG检测早期心脏失灵风险。 Samsung's Galaxy Watch AI feature detects early heart failure risk via ECG, approved in South Korea, with no launch date set.

Samsung正在为其银河监视系统开发一个AI动力功能,以利用100多所南韩医院已经使用的12个领先ECG模型,检测心脏衰竭的一个主要原因 -- -- 左心心管功能(LVSD)。 Samsung is developing an AI-powered feature for its Galaxy Watch to detect Left Ventricular Systolic Dysfunction (LVSD), a leading cause of heart failure, using a 12-lead ECG model already used in over 100 South Korean hospitals. 该技术是用医疗人工智能创建的,旨在及早进行无症状的检测,以减少住院和死亡。 The technology, created with Medical AI, aims to enable early, asymptomatic detection to reduce hospitalizations and deaths. 它已经获得南朝鲜的监管批准,并正在朝未来发射的方向迈进,尽管尚未确定日期。 It has received regulatory approval in South Korea and is progressing toward a future launch, though no date has been set. 与此同时,三星正与汉阳大学测试一个耳状EEG原型原型,以监测脑电波对沉睡和用户偏好的影响,显示出神经营销和娱乐的潜力,尽管仍处于早期开发阶段。 In parallel, Samsung is testing an ear-worn EEG prototype with Hanyang University to monitor brainwaves for drowsiness and user preferences, showing potential in neuromarketing and entertainment, though it remains in early development.